Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charles Klazer Gomes"'
Autor:
Erin J. Stephenson, Amanda S. Stayton, Aarti Sethuraman, Prahlad K. Rao, Alice Meyer, Charles Klazer Gomes, Molly C. Mulcahy, Liam McAllan, Michelle A. Puchowicz, Joseph F. Pierre, Dave Bridges, Joan C. Han
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
Dietary sugar intake may contribute to the development non-alcoholic fatty liver disease. Here the authors investigated the effects of chronic dietary sucrose on the liver-adipose-microbiome axis in mice, and report that sex is a moderating factor th
Externí odkaz:
https://doaj.org/article/3fba10da99634f7895ece1db8569a6fc
Autor:
Elsa Fortes-Gabriel, Mariana Soares Guedes, Advait Shetty, Charles Klazer Gomes, Teresa Carreira, Maria Luísa Vieira, Lisa Esteves, Luísa Mota-Vieira, Maria Gomes-Solecki
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 2, p e0010241 (2022)
The laborious microscopic agglutination test (MAT) is the gold standard serologic test for laboratory diagnosis of leptospirosis. We developed EIA based serologic assays using recombinant proteins (rLigA, rLigB, rLipL32) and whole-cell extracts from
Externí odkaz:
https://doaj.org/article/bcc39d8ac0cb48839bd71f392e6a634e
Autor:
Elsa Fortes-Gabriel, Mariana Soares Guedes, Advait Shetty, Charles Klazer Gomes, Teresa Carreira, Maria Luísa Vieira, Lisa Esteves, Luísa Mota-Vieira, Maria Gomes-Solecki
Publikováno v:
PLoS neglected tropical diseases. 16(2)
The laborious microscopic agglutination test (MAT) is the gold standard serologic test for laboratory diagnosis of leptospirosis. We developed EIA based serologic assays using recombinant proteins (rLigA, rLigB, rLipL32) and whole-cell extracts from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d8ff3b9a6c86709c283ad353fd27052
https://pubmed.ncbi.nlm.nih.gov/35196321
https://pubmed.ncbi.nlm.nih.gov/35196321
Autor:
Erin J. Stephenson, Amanda S. Stayton, Aarti Sethuraman, Prahlad K. Rao, Alice Meyer, Charles Klazer Gomes, Molly C. Mulcahy, Liam McAllan, Michelle A. Puchowicz, Joseph F. Pierre, Dave Bridges, Joan C. Han
Publikováno v:
Nature communications. 13(1)
Almost all effective treatments for non-alcoholic fatty liver disease (NAFLD) involve reduction of adiposity, which suggests the metabolic axis between liver and adipose tissue is essential to NAFLD development. Since excessive dietary sugar intake m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a3cc776ea1cee5ffd25c1ff3cb8983
https://pubmed.ncbi.nlm.nih.gov/36229459
https://pubmed.ncbi.nlm.nih.gov/36229459